Form 4 for HQL abrdn Life Sciences Investors
Accepted 2024-01-02 00:00:00 ET · period of report 2023-12-28 · accession 0001104659-24-000358 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-02 | 2023-12-28 | HQL | Maher Bill | Dir | P - Purchase | $13.57 | +1,000 | 1,000 | New | +$13.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-28 | P | A | 1,000 | $13.57 | 1,000 | D | — | — |